Your browser does not support JavaScript!

Fabricants distributeurs d'instruments de mesure

389 entreprises et organismes intervenants dans le domaine 'Instruments de mesure', classés par activité.

Rejoignez la communauté
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 6 jours

Merck, BMS chip into PathAI’s series B, bringing total to $75M

Il y a 1 semaine
Seven months after banking $60 million, PathAI is at it again. Bristol-Myers Squibb and Merck Global Health Innovation Fund is adding $15 million to the digital pathology player’s series B....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 6 jours

Merck taps Promega for new Keytruda microsatellite instability diagnostic

Il y a 1 semaine
Merck will work with Promega to develop the biological analysis company’s microsatellite instability technology into an official, on-label companion diagnostic for its Keytruda immunotherapy in solid...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 3 semaines

After $700M-plus Merck buyout, Tilos CEO Fox lands at Rheos Medicines

Il y a 3 semaines
Barbara Fox, Ph.D., is getting right back on the horse. Fresh off Tilos Therapeutics’ $773 million sale to Merck, Fox is taking the helm of another Cambridge, Massachusetts-based company: Rheos...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 11/10/2019

EuroBiotech Report—UCB inks $2.5B deal; Oxford spinout; Bayer, Merck and Gilead

Le 10/10/2019
In this week's EuroBiotech Report, UCB inks $2.5 billion Ra takeout, MiroBio raises £27 million and Bayer forms Riken drug discovery pact. ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 09/10/2019

UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome

Le 08/10/2019
Merck will pay the microbiome company 4D Pharma up to €316.5M to develop vaccines based on delivering live bacteria to the gut. The partners will develop vaccines against three undisclosed conditions....
www.labiotech.eu
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 01/10/2019

ESMO: AbbVie's PARP inhibitor veliparib finally gets a win, but can it compete?

Le 29/09/2019
BARCELONA—Quietly, and without the fanfare of gene and cell therapies, PARP inhibitors from the likes of AstraZeneca, Merck and GlaxoSmithKline/Tesaro have been racking up big trial wins in breast and...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 20/09/2019

Black Diamond grabs trio of new R&D execs as it barrels toward the clinic

Le 19/09/2019
After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up its research work....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 18/09/2019

Merck's Ebola vaccine tees up FDA date, aiming for first status

Le 17/09/2019
Merck will learn whether the FDA will approve its Ebola vaccine V920 by mid-March, giving it a shot at becoming the first company to receive clearance to sell a vaccine against the virus in the U.S....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 29/08/2019

Never Give Up on Your Job Hunt During the Holidays!

Le 28/08/2019
Hello biotechies, Job hunt frustration? Don’t worry, we’re here to help. Check out the offer from GSK or become an Account Manager at Merck. Just starting out? Check out the internship at ADOCIA! ...
labiotech.eu
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 23/08/2019

Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’

Le 22/08/2019
Vienna-based Themis Bioscience will develop vaccine candidates against an undisclosed disease target in partnership with big pharma Merck Sharp & Dohme. As part of the agreement, MSD will provide...
labiotech.eu
Charger plus d'actualités